Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Stable Maintenance Renal Transplant Patients: Pooled Results From Three International, Multicenter Studies

Transplantation Proceedings

Volumn 39, Issue 1, 2007, Pages 103-108

  Pietruck, F ^a,f   Abbud Filho, M ^b,f   Vathsala, A ^c,f   Massari, P U ^d,f   Po Huang, L ^e,f   Nashan, B ^f  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Institute for Urology and Nephrology   (Brazil)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d HOSPITAL PRIVADO   (Argentina)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; THYMOCYTE ANTIBODY;

ANEMIA; ARTICLE; BIOEQUIVALENCE; BLOOD DISEASE; BREAST DISEASE; CANCER; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CONSTIPATION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERIC COATED TABLET; EYE DISEASE; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; GENITAL SYSTEM DISEASE; GRAFT SURVIVAL; HEART DISEASE; HEPATOBILIARY DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKEMIA; LEUKOPENIA; LOOSE FECES; LOWER ABDOMINAL PAIN; LYMPHATIC SYSTEM DISEASE; MEDIASTINUM DISEASE; MENTAL DISEASE; META ANALYSIS; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; POLYCYTHEMIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RHINOPHARYNGITIS; SKIN CARCINOMA; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; THORAX DISEASE; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; URINARY DYSFUNCTION; URINARY TRACT INFECTION; VASCULAR DISEASE; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; CHILD; GASTROINTESTINAL DISEASES; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MYCOPHENOLIC ACID; PATIENT SELECTION; REOPERATION; TABLETS, ENTERIC-COATED; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33846648725     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.216     Document Type: Article

References (14)

1. Sollinger H.W., and US Renal Transplant Mycophenolate Renal Transplantation Study Group. Mycophenolate mofetil for the prevention of acute rejection in cadaveric renal allograft recipients. Transplantation 60 (1995) 225
2. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for the prevention of acute rejection. Lancet 345 (1995) 1321
3. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61 (1996) 1029
4. Meier-Kriesche H.U., Ojo A.O., and Leichtman A.B. Effect of mycophenolate mofetil on long-term outcomes in African American renal transplant recipients. J Am Soc Nephrol 11 (2000) 2366
5. Ojo A.O., Meier-Kriesche H.U., and Hanson J.A. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 69 (2000) 2405
6. Behrend M. Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. Drug Saf 24 (2001) 645
7. Pelletier R.P., Akin B., and Henry M.L. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transpl 17 (2002) 200
8. Knoll G.A., MacDonald I., and Khan A. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 14 (2003) 2381
9. Hardinger K.L., Brennan D.C., and Lowell J. Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int 17 (2004) 609
10. Tierce J.C., Porterfield-Baxa J., and Petrilla A.A. Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients. Clin Transplant 19 (2005) 779
11. Salvadori M., Holzer H., de M.A., and The ERL B301 Study Groups. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 4 (2004) 231
12. Budde K., Curtis J., and Knoll G. Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study. Am J Transplant 4 (2004) 237
13. Budde K., Knoll J., and Curtis J. Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study. Transplant Proc 37 (2005) 921
14. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31